Lassam N - Search Results

1

Melanoma in adolescents: a case-control study of risk factors in Queensland, Australia.

Youl P, Aitken J, Hayward N, Hogg D, Liu L, Lassam N, Martin N, Green A. Youl P, et al. Among authors: lassam n. Int J Cancer. 2002 Mar 1;98(1):92-8. doi: 10.1002/ijc.10117. Int J Cancer. 2002. PMID: 11857391 Free article.

2

Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.

Lynch HT, Brand RE, Hogg D, Deters CA, Fusaro RM, Lynch JF, Liu L, Knezetic J, Lassam NJ, Goggins M, Kern S. Lynch HT, et al. Among authors: lassam nj. Cancer. 2002 Jan 1;94(1):84-96. doi: 10.1002/cncr.10159. Cancer. 2002. PMID: 11815963 Free article.

3

Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.

Lal G, Liu L, Hogg D, Lassam NJ, Redston MS, Gallinger S. Lal G, et al. Among authors: lassam nj. Genes Chromosomes Cancer. 2000 Apr;27(4):358-61. Genes Chromosomes Cancer. 2000. PMID: 10719365

4

CDKN2A mutation in a non-FAMMM kindred with cancers at multiple sites results in a functionally abnormal protein.

Sun S, Pollock PM, Liu L, Karimi S, Jothy S, Milner BJ, Renwick A, Lassam NJ, Hayward NK, Hogg D, Narod SA, Foulkes WD. Sun S, et al. Among authors: lassam nj. Int J Cancer. 1997 Nov 14;73(4):531-6. doi: 10.1002/(sici)1097-0215(19971114)73:4<531::aid-ijc13>3.0.co;2-c. Int J Cancer. 1997. PMID: 9389568 Free article.

5

Malignant melanoma in patients with multiple endocrine neoplasia type 1 and involvement of the MEN1 gene in sporadic melanoma.

Nord B, Platz A, Smoczynski K, Kytölä S, Robertson G, Calender A, Murat A, Weintraub D, Burgess J, Edwards M, Skogseid B, Owen D, Lassam N, Hogg D, Larsson C, Teh BT. Nord B, et al. Among authors: lassam n. Int J Cancer. 2000 Aug 15;87(4):463-7. doi: 10.1002/1097-0215(20000815)87:4<463::aid-ijc1>3.0.co;2-8. Int J Cancer. 2000. PMID: 10918183 Free article.

6

Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19ARF.

Liu L, Goldstein AM, Tucker MA, Brill H, Gruis NA, Hogg D, Lassam NJ. Liu L, et al. Among authors: lassam nj. Genes Chromosomes Cancer. 1997 May;19(1):52-4. Genes Chromosomes Cancer. 1997. PMID: 9135995

7

Germline splicing mutations of CDKN2A predispose to melanoma.

Loo JC, Liu L, Hao A, Gao L, Agatep R, Shennan M, Summers A, Goldstein AM, Tucker MA, Deters C, Fusaro R, Blazer K, Weitzel J, Lassam N, Lynch H, Hogg D. Loo JC, et al. Among authors: lassam n. Oncogene. 2003 Sep 25;22(41):6387-94. doi: 10.1038/sj.onc.1206736. Oncogene. 2003. PMID: 14508519

8

Genetic Testing in Familial Melanoma : Epidemiologic/Genetic Assessment of Risks and Role of CDKN2A Analysis.

Hogg D, Liu L, Lassam N. Hogg D, et al. Among authors: lassam n. Methods Mol Med. 2001;61:109-22. doi: 10.1385/1-59259-145-0:109. Methods Mol Med. 2001. PMID: 22323255

9

Germline CDKN2A mutation implicated in predisposition to multiple myeloma.

Dilworth D, Liu L, Stewart AK, Berenson JR, Lassam N, Hogg D. Dilworth D, et al. Among authors: lassam n. Blood. 2000 Mar 1;95(5):1869-71. Blood. 2000. PMID: 10688850 Free article.

10

Role of the cyclin-dependent kinase inhibitor CDKN2A in familial melanoma.

Hogg D, Brill H, Liu L, Monzon J, Summers A, From L, Lassam NJ. Hogg D, et al. Among authors: lassam nj. J Cutan Med Surg. 1998 Jan;2(3):172-9. doi: 10.1177/120347549800200312. J Cutan Med Surg. 1998. PMID: 9479083 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page